君圣泰医药-B（股票代码：02511）2026年8月3日发布公告，披露截至2026年7月31日的证券变动月报表。报告期内，公司法定/注册股本及已发行股份数未发生任何增减变动。
根据公告，君圣泰医药-B法定/注册股本数为1,000,000,000股，面值每股USD 0.0001，法定/注册股本总额维持USD 100,000不变。公司已发行股份总数为571,325,668股，库存股数目为零，无新增发行或购回、注销及库藏股活动。
公告显示，君圣泰医药-B在报告期内无股份期权、权证、可转换债券或其他与发行人股份相关的相关变动及安排。公司同时确认符合香港联交所的最低公众持股量要求，并持续遵守香港联交所《上市规则》及相关法律法规。
截至2026年7月31日，公司总股本保持不变。该公告由执行董事兼行政总裁刘利平博士签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.